MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Decline in Motor Function and Cognitive Abilities in GBA PD Compared to Idiopathic PD (iPD)

    B. Mangal, C. Edgar, O. Siddiqui, M. Facheris, M. Hagey, D. Weintraub, T. Simuni (Chicago, USA)

    Objective: To compare disease progression events between GBA PD and iPD using the Parkinson’s Progression Markers Initiative (PPMI) database Background: GBA PD patients exhibit more…
  • 2025 International Congress

    Impact of parkinson’s disease on work disability: a cross-sectional study

    S. Secades, C. Martin (Madrid, Spain)

    Objective: To evaluate the impact of Parkinson’s disease (PD) on work disability and identify clinical and demographic factors associated with occupational impairment. Additionally, this study…
  • 2025 International Congress

    Elucidating Tau and Alpha-synuclein Co-pathology in RAB39b X-linked Parkinson’s Disease.

    M. Kim, A. Park, E. Chiu, J. Weiss, S. Yu, D. Yearout, C. Zabetian, O. Betancour, M. Davis (Seattle, USA)

    Objective: Elucidate the mechanisms underlying pathogenesis of X-linked Parkinson’s disease (PD) due to the RAB39B p.G192R mutation. Background: RAB39B p.G192R causes X-linked PD with decreased…
  • 2025 International Congress

    The Impact of Microgravity and Herpes Simplex Virus 1 on Parkinson’s Neurodegeneration and HERV Expression

    ER. Simula, S. Jasemi, D. Cossu, I. Cossu, M. Fais, M. Noli, LA. Sechi (Sassari, Italy)

    Objective: The present abstract aims to investigate the impact of viral infections and microgravity exposure in the context of Parkinson’s disease (PD). Background: PD is…
  • 2025 International Congress

    Utilising Beta Power in Local Networks to Predict Freezing of Gait Events in Parkinson’s Disease

    Y. Tian, E. Matar, S. Lewis (Sydney, Australia)

    Objective: Our study examined brain network changes during the transition to Freezing of Gait (FOG) versus voluntary stopping. Identifying specific neural alterations may help establish…
  • 2025 International Congress

    Fatty Acid Metabolic Reprogramming Regulates Glial-Epithelial Axis via Nur77 Palmitoylation in Intestinal Dysfunction in Parkinson’s Disease

    J. Zou, Z. Deng, Z. Lu, X. Luo, F. Yu, W. Bi (Guangzhou, China)

    Objective: This study aims to elucidate the regulatory role of stearoyl-CoA desaturase 1 (SCD1) in Parkinson’s disease (PD)-associated intestinal dysfunction, focusing on its mechanism in…
  • 2025 International Congress

    Identification of Distinctive Iron Deposition Pattern in Subcortical Nuclei of Parkinson’s Disease using Radiomics: A 7T Susceptibility-Weighted Imaging Study

    T. Feng, DN. Su, SD. Ding, ZJ. Zhang, Z. Zhang, J. Jing (Beijing, China)

    Objective: To develop the optimal radiomics signature of distinctive subcortical nuclei iron deposition pattern for diagnosis and differential diagnosis of Parkinson’s disease (PD) at 7T susceptibility-weighted imaging (SWI).…
  • 2025 International Congress

    Dopaminergic and Synaptic Alterations in SWEDD: Insights from [¹⁸F] FE-PE2I and [¹¹C] UCB-J PET Imaging

    F. Ebrahimian Sadabad, T. Volpi, P. Honhar, L. Colon, S. Tinaz, M. Naganawa, M. Dias, G. Angarita, R. Comley, R. Carson, S. Finnema, D. Matuskey (Tallahassee, USA)

    Objective: To investigate dopaminergic and synaptic density in SWEDD patients compared to idiopathic Parkinson’s disease (IPD) and healthy controls (HCs). Background: Scans Without Evidence of…
  • 2025 International Congress

    A novel potential imaging biomarker for Parkinson’s disease: Optical Coherence Tomography.

    G. Napoli, R. Santangelo, G. Rugarli, R. Balestrino, E. Sarasso, L. Ferini-Strambi, M. Filippi, F. Agosta (Milan, Italy)

    Objective: This observational cross-sectional study aims to explore the thickness of retinal layers in patients within the PD continuum, patients with isolated REM Sleep Behavior…
  • 2025 International Congress

    The regulatory variant c.–253C>T of the DNAJC13 gene as a causal factor for Parkinson’s disease in a patient with early-onset

    J. Hoenicka, A. Pascual, P. García-Ruíz, X. Castro-Martínez, R. Repossi, O. de Fabregues, L. Vela-Desojo, M. Mata, I. Torres, JC. Martinez-Castrillo, F. Palau, G. Fernandez (Mexico City, Mexico)

    Objective: This work aims to investigate the role of regulatory regions in Parkinson’s disease (PD) genes, which may help explain part of the missing heritability.…
  • « Previous Page
  • 1
  • …
  • 109
  • 110
  • 111
  • 112
  • 113
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley